⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S6 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression

Chuandong Geng Man-Chao Zhang Ganiraju C. Manyam Jody V. Vykoukal Johannes F. Fahrmann Shan Peng Cheng Wu Sanghee Park Shakuntala Kondraganti Daoqi Wang Brian D. Robinson Massimo Loda Christopher E. Barbieri Timothy A. Yap Paul G. Corn Samir Hanash Bradley M. Broom Patrick G. Pilié Timothy C. Thompson

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Fig. S6. Far western blotting assay to detect direct protein-protein interaction of SPOP and STING protein in vitro

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Geng et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db6435875226d0 https://doi.org/10.1158/1078-0432.27034297

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S6 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
2Supplementary Figure S14 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
3Supplementary Figure S14 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
4Supplementary Figure S17 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
5Supplementary Figure S17 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024

More related papers

Supplementary Figure S15 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
Supplementary Figure S16 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024
Supplementary Figure S7 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression2024